- Darren Tobin | May 21, 2012 3:34 PM | Atlanta, GA
Category:
FDA & Prescription Drugs
Ever wonder how to find out exactly what inactive ingredients are in medication? Most people do not know or care to know what inactive ingredients are in the drug they are about to take, but some...
- M. Brandon Smith | September 25, 2011 11:09 PM | Atlanta, GA
Category:
FDA & Prescription Drugs
An increased risk of developing bladder cancer has been linked to the diabetes drug Actos (generic: pioglitazone). The increased risk of developing bladder cancer is a staggering 40%.
Actos was...
- Darren Tobin | September 19, 2011 1:49 PM | Atlanta, GA
Category:
FDA & Prescription Drugs
Patients who have been taking ACTOS, a popular diabetes drug, have been warned by the FDA that there is an increase in the risk of bladder cancer when the drug is ingested for more than 12 months....
- Darren Tobin | September 14, 2011 10:11 AM | Atlanta, GA
Category:
FDA & Prescription Drugs
The FDA recently issued a warning regarding ACTOS and the risk of developing bladder cancer. There have been recent studies suggesting that patients who take ACTOS longer than 12 months increase the...
- Darren Tobin | August 31, 2011 5:38 PM | Atlanta, GA
Category:
Defective & Dangerous Products
Public Citizen, a consumer advocacy group representing more than 225,000 members and supporters nationwide, has petitioned the U.S. Food and Drug Administration to ban the current use of surgical...
- Darren Tobin | August 09, 2011 10:35 AM | Atlanta, GA
Category:
FDA & Prescription Drugs
Actos (pioglitazaone) has recently been associated with the risk of bladder cancer, according to the FDA. On August 4, 2011, the FDA approved updated drug labels for the pioglitazone-containing...